BriaCell and BriaPro Announce Closing of Asset Purchase Transaction for Exclusive Soluble CD80 License [Yahoo! Finance]
BriaCell and BriaPro Announce Closing of Asset Purchase Transaction for Exclusive Soluble CD80 License [TheStreet.com]
BriaCell and BriaPro Announce Closing of Asset Purchase Transaction for Exclusive Soluble CD80 License
BriaCell to Present Positive Clinical Data for Bria-IMT™ and Preclinical Data for Next Generation Bria-OTS+™ Personalized Immunotherapy at the 2026 AACR Conference [Yahoo! Finance]